Navigation Links
Omeros Submits New Drug Application to U.S. FDA for OMS302
Date:8/1/2013

SEATTLE, Aug. 1, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) announced that the company recently submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for approval of OMS302 for use in patients undergoing intraocular lens replacement (ILR) surgery. Added to standard irrigation solution used during ILR, OMS302 is Omeros' proprietary PharmacoSurgery™ product that, across multiple human trials, demonstrated clinically meaningful and statistically significant maintenance of intraoperative mydriasis (pupil dilation), prevention of intraoperative miosis (pupil constriction), and reduction of postoperative ocular pain.

In addition, Omeros plans to submit a Marketing Authorization Application to the European Medicines Agency (EMA) via the EMA's centralized procedure this quarter. The company has recently been granted designation by the EMA as a Small or Medium-Sized Enterprise (SME). Through the SME program, Omeros can benefit from elimination or reduction of certain fees related to the clinical development and approval processes in Europe for OMS302 and other Omeros products.

"OMS302 fills a need recognized by all ophthalmic surgeons and does so without requiring them to change their routine operating procedures," stated Eric B. Donnenfeld, M.D., clinical professor of ophthalmology at New York University and president of the American Society of Cataract and Refractive Surgery. "Based on the results of the clinical trials, OMS302 has the potential to improve outcomes in all lens replacement surgeries. I look forward to being able to use the product in my practice – it provides benefits to both patients and their surgeons."

"This NDA submission represents the culmination of a tremendous amount of work by the Omeros team and our collabor
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , June 29, 2015 BiondVax ... preliminary results from its BVX-006 Phase II clinical trial ... In this trial, M-001 was injected intramuscularly to volunteers ... an administration of the 2014/15 season trivalent influenza vaccine ... safe and well tolerated and induced humoral immune responses, ...
(Date:6/29/2015)... 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... Russell 1000 Index, effective June 26, 2015. The Russell ... of the U.S. equity universe. It is a subset ... of the largest securities based on a combination of ... "We are pleased to be added to this important ...
(Date:6/29/2015)... SAN JOSE, Calif. , June 29, 2015 ... its expert medical workstation lineup. The high-powered, multi-functional ... th generation Intel® Haswell Core ... processor. Both provide significant data processing and computing ... visual performance, making the unit well suited for ...
Breaking Medicine Technology:BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
(Date:6/30/2015)... ... June 30, 2015 , ... Izenda is proud to acknowledge ... currently attending an accredited American educational institution through its scholarship program. , In ... healthcare, the environment, political campaigns, and a variety of other worldwide trends. Modern ...
(Date:6/30/2015)... ... 2015 , ... Americans report feeling more stressed than ever before. There’s even ... stressed out people right over the edge. , Almost half of Americans report ... night. Sleeping pills now lead the list of the most prescribed medications, despite reported ...
(Date:6/30/2015)... ... June 30, 2015 , ... Scott Purdy, the spokesperson for Dephinitive Systems LLC, ... Purdy stated that the XO stands for eXtra Operability (XO) which was chosen to ... of the Revenue Cycle. , Provider XO, based in Cleveland OH, is part ...
(Date:6/30/2015)... , ... June 30, 2015 , ... “It is never ... of SunGrubbies.com. “We are particularly interested in getting the word out to children ... to surface. We are extremely pleased with our new video which we ...
(Date:6/29/2015)... ... 30, 2015 , ... Sublime Beauty NATURALS® introduces its new USDA Certified Organic ... for natural skincare and even culinary uses, was especially designed for Oil Pulling. ... and Oil Pulling can accomplish this. Oil Pulling is an Ayurvedic practice that is ...
Breaking Medicine News(10 mins):Health News:Izenda Offers Embedded BI and Analytics Scholarship 2Health News:Izenda Offers Embedded BI and Analytics Scholarship 3Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 2Health News:Wake UP Happy and Sleep Soundly with Famous Experts with My Wake UP Call® Motivational Alarm Clock® Messages and My Good Night Messages™ - Now Available at Audible! 3Health News:Dephinitive Systems Is Getting a New Name 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 3Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2
... 13 The American Association of Homes and ... than 60 aging and disability organizations to urge ... a part of health care reform legislation.The groups ... Call today and on a Congressional call-in ...
... CINCINNATI, May 13, 2009 Today, the United States ... favor of The Procter & Gamble Company (P&G) in ... Pharmaceuticals USA, Inc. The positive ruling protects P&G,s ... therapy Actonel(R) (risedronate sodium) tablets. Actonel is commercialized ...
... Irvine, Calif., May 13, 2009 A potential vaccine ... to slow the weakening of muscles associated with inclusion ... The finding brings new hope for IBM patients with ... wrists, forearms or quadriceps. There is no cure for ...
... 2009 Orange County Arthritis Walk(R)IRVINE, Calif., May 13 ... the Arthritis Foundation. The Orange County Great Park ... County Arthritis Walk(R) set to take place on Sunday, ... Foundation,s annual nationwide event to raise funds for arthritis ...
... The decision by the Centers for ... colonography, also known as "virtual" colonoscopy, a radiographic examination ... on the test,s potential as an appropriate option for ... of the primary issues identified by CMS is that ...
... 13 At a congressional hearing today in Washington, ... of Veterans Affairs to immediately expand use of ViziLite(R) ... oral abnormalities that could lead to cancer. David Bethune, ... ZILA ), developer and marketer of ViziLite Plus, addressed ...
Cached Medicine News:Health News:AAHSA Joins Sixty Aging and Disability Groups to Fight for Long-Term Services and Supports in Health Care Reform 2Health News:Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel 2Health News:Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel 3Health News:Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel 4Health News:Vaccine slows progression of skeletal muscle disorder 2Health News:Take a Walk in the Great Park to Benefit the Arthritis Foundation 2Health News:Decision by Medicare's CMS to Deny Coverage for 'Virtual' Colon Cancer Tests Underscores Lack of Evidence on Cancer Prevention 2Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 2Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 3Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 4Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 5Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 6Health News:Zila & Experts Testify at Congressional Hearing on Innovative Technology for Veterans; Urge Broader Use of ViziLite(R) Plus by VA for Oral Cancer Screening 7
... curtains or parting strip shields ... frame to form a free-standing, ... cleanliness to Class 10/ISO 3. ... lights, and ionizers are configured ...
Inquire...
Inquire...
Inquire...
Medicine Products: